Lifecore Biomedical, Inc.
LFCR · NASDAQ
9/30/2025 | 5/25/2025 | 2/23/2025 | 11/24/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -14.6% | 3.7% | 8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25% | 38.4% | 28% | 34% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -22.9% | 17.3% | -20.5% | 3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.1% | -3.1% | -42% | -20.2% |
| EPS Diluted | -0.29 | -0.055 | -0.47 | -0.25 |
| % Growth | -424.4% | 88.2% | -88% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |